Drugs / PluroGel
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05000983 | Oct 2021 → Nov 2028 expected | — | University of Manitoba | Recruiting | No outcome recorded |
| Phase 1/2 | NCT04893863 | Oct 2021 → Dec 2028 expected | — | University of Manitoba | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PluroGel | “Plurogel® is approved for use in burn injuries in Canada, however there are no randomized control trials (RCTs) to support its use.” NCT05000983 ↗3“PluroGel® is a concentrated surfactant in the form of a stable, viscous gel.” NCT04893863 ↗ |
| Modality | Other / unclassified | “PluroGel® is a concentrated surfactant in the form of a stable, viscous gel.” NCT04893863 ↗ |
| Route | Topical | “A 0.5 cm layer of PluroGel® followed by the above standard dressing.” NCT05000983 ↗ |